Safety and Efficacy of BKM120 and Lapatinib in HER2+/PI3K-activated, Trastuzumab-resistant Advanced Breast Cancer
Clinical trial NCT01589861 · TERMINATED
Trial details
- NCT number
- NCT01589861
- Sponsor
- Institut Paoli-Calmettes
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-12-01
- Primary completion
- 2017-10-10
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.